Lowering Lp(a) Did Not Prevent Heart Attacks in the First Outcome Trial
Community vote
No Bro-Meter votes yet. Be the first. The verdict is only these votes — not FDA pages, imports, or ads.
Tried-it reports
Lived experience sits next to the community vote. Official sources never override either.
Imported from Reddit r/longevity. Filed by the system importer, not a fake user. Original post: https://www.reddit.com/r/longevity/comments/1xukghz/lowering_lpa_did_not_prevent_heart_attacks_in_the/ Possible receipts (auto-attached from public APIs — verify before trusting; they do not decide the Bro-Meter): - PubMed: Lipoprotein(a) in Cardiovascular Disease: Integrating Epidemiology, Clinical Guidelines, Molar Measurement, and Emerging Therapies — https://pubmed.ncbi.nlm.nih.gov/43021708/ - PubMed: Extended Analyses of Pelacarsen and Cardiovascular Outcomes in Patients with High Lipoprotein(a) — https://pubmed.ncbi.nlm.nih.gov/42998055/ - ClinicalTrials.gov: 4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease — https://clinicaltrials.gov/study/NCT01587924
Votes and comments are community opinion, not professional advice.
Comments (1)
one trial. i'd wait for the others before calling lp(a) lowering pointless